Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01928667
Other study ID # NL44127.068.13
Secondary ID
Status Completed
Phase N/A
First received August 21, 2013
Last updated July 18, 2016
Start date July 2014
Est. completion date July 2016

Study information

Verified date July 2016
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Observational

Clinical Trial Summary

The purpose of the study is to assess among others environmental and hygiene-related risk factors for microscopic colitis (MC), a common diarrheal disease.


Recruitment information / eligibility

Status Completed
Enrollment 487
Est. completion date July 2016
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Confirmed Diagnosis of MC (CC or LC) between January 1, 2000 and December 31, 2012.

- Inhabitant of the province of Limburg or the Eindhoven region at the moment of diagnosis

Exclusion Criteria:

- Below 18 years of age at the time of diagnosis

- Not capable of signing an informed consent

- Deceased at moment of approximation

Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Intervention

Other:
Whole saliva sample
Both case and control group will be approached to consider to give permission to sample saliva. This is not obligatory. Collected samples will be stored for future DNA research.

Locations

Country Name City State
Netherlands Maastricht UMC Maastricht Limburg

Sponsors (1)

Lead Sponsor Collaborator
Maastricht University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of environmental and hygiene-related risk factors for microscopic colitis Information about environmental and hygiene-related risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012 Retrospective, between 2000 and 2012 No
Secondary The difference between the CC and LC subpopulation regarding environmental, hygiene-related, and generally known risk factors As generally known risk factors are considered: age, gender, medication, comorbidities and smoking.
Information about risk factors is obtained by a questionnaire, sent to subjects diagnosed with MC between 2000 and 2012.
Retrospective between 2000 and 2012 No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05998174 - Faecal Microbiota Transplantation for Microscopic Colitis Early Phase 1
Recruiting NCT05058131 - Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre N/A
Completed NCT02303132 - Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis N/A
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Recruiting NCT06031064 - External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea
Recruiting NCT04043897 - Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis Phase 2
Recruiting NCT06172647 - Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer
Recruiting NCT03477032 - FMT in Inflammatory Bowel Disease
Completed NCT03275467 - Faecal Microbiota Transplantation in Patients With Microscopic Colitis N/A
Completed NCT00180050 - Budesonide Treatment for Lymphocytic Colitis Phase 3
Not yet recruiting NCT05915104 - Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis Phase 2
Completed NCT00952952 - Trial of Mesalamine for the Treatment of Active Microscopic Colitis Phase 2/Phase 3